IL157264A0 - Platelet glycoprotein ib alpha fusion polypeptides and methods of use thereof - Google Patents

Platelet glycoprotein ib alpha fusion polypeptides and methods of use thereof

Info

Publication number
IL157264A0
IL157264A0 IL15726402A IL15726402A IL157264A0 IL 157264 A0 IL157264 A0 IL 157264A0 IL 15726402 A IL15726402 A IL 15726402A IL 15726402 A IL15726402 A IL 15726402A IL 157264 A0 IL157264 A0 IL 157264A0
Authority
IL
Israel
Prior art keywords
methods
fusion polypeptides
platelet glycoprotein
alpha fusion
alpha
Prior art date
Application number
IL15726402A
Other languages
English (en)
Original Assignee
Inst Genetics Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Genetics Llc filed Critical Inst Genetics Llc
Publication of IL157264A0 publication Critical patent/IL157264A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Cardiology (AREA)
  • Toxicology (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Epidemiology (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Otolaryngology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IL15726402A 2001-02-06 2002-02-06 Platelet glycoprotein ib alpha fusion polypeptides and methods of use thereof IL157264A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US26683801P 2001-02-06 2001-02-06
PCT/US2002/003549 WO2002063003A2 (en) 2001-02-06 2002-02-06 Platlet glycoprotein ib alpha fusion polypeptides and methods of use thereof

Publications (1)

Publication Number Publication Date
IL157264A0 true IL157264A0 (en) 2004-02-19

Family

ID=23016192

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15726402A IL157264A0 (en) 2001-02-06 2002-02-06 Platelet glycoprotein ib alpha fusion polypeptides and methods of use thereof

Country Status (16)

Country Link
US (5) US6991796B2 (xx)
EP (1) EP1360292A2 (xx)
KR (1) KR20030074796A (xx)
CN (1) CN100523188C (xx)
AR (1) AR035779A1 (xx)
AU (3) AU2002240287B2 (xx)
BR (1) BR0207039A (xx)
CA (1) CA2437714A1 (xx)
HU (1) HUP0303167A2 (xx)
IL (1) IL157264A0 (xx)
MX (1) MXPA03007010A (xx)
NO (1) NO20033474L (xx)
NZ (1) NZ528037A (xx)
PL (1) PL373052A1 (xx)
WO (1) WO2002063003A2 (xx)
ZA (1) ZA200306229B (xx)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR035779A1 (es) * 2001-02-06 2004-07-14 Genetics Inst Llc Polipeptidos de fusion derivados de glicoproteina ib alfa de plaqueta y metodos de uso de los mismos
CN100436480C (zh) * 2003-06-11 2008-11-26 韦思公司 血小板糖蛋白IB-α变体融合多肽及其用法
JP2005073528A (ja) * 2003-08-28 2005-03-24 Genetics Inst Llc 生物学的系における生物学的組織への血球の接着を阻害する方法、ならびにその方法に使用するための組成物
NZ550772A (en) * 2004-05-21 2009-10-30 Uab Research Foundation Variable lymphocyte receptors, related polypeptides and nucleic acids, and uses thereof
US20080015145A1 (en) 2006-07-11 2008-01-17 Maria Gyongyossy-Issa Mimotope receptors and inhibitors for platelet-platelet and platelet-endothelium interactions
DE102007031708A1 (de) 2007-07-06 2009-01-08 Dade Behring Marburg Gmbh Bestimmung der von Willebrand Faktor-Aktivität in Abwesenheit von Ristocetin
WO2010071934A1 (en) * 2008-12-22 2010-07-01 Baker Idi Heart And Diabetes Institute Holdings Limited Modulation of platelet activation
CN102988983B (zh) * 2011-09-09 2014-06-11 苏州苏大赛尔免疫生物技术有限公司 抗人血小板膜糖蛋白Ibα嵌合抗体药物组合物
EP2794007A4 (en) * 2011-12-23 2015-11-18 Vasculogics Inc COMPOSITIONS AND METHODS FOR TREATING THROMBOSES AND EXTENDING THE LIFE OF THE STORED THROMBOCYTES
CN104519989B (zh) 2012-06-26 2016-10-26 通用电气医疗集团股份有限公司 制备包含气体微泡的组合物
ES2614352T3 (es) * 2014-03-11 2017-05-30 Siemens Healthcare Diagnostics Products Gmbh Método para la detección de moduladores de la interacción de GPIb-trombina
CN107340225B (zh) * 2017-07-13 2019-07-05 徐州医科大学 一种基于流式细胞术检测血小板受体GPIba胞外段酶切的方法
CA3086449A1 (en) 2018-02-20 2019-08-29 Grifols Diagnostic Solutions Inc. Composition comprising recombinant gpiba receptor protein

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4485045A (en) 1981-07-06 1984-11-27 Research Corporation Synthetic phosphatidyl cholines useful in forming liposomes
US4544545A (en) 1983-06-20 1985-10-01 Trustees University Of Massachusetts Liposomes containing modified cholesterol for organ targeting
US5340727A (en) * 1987-11-17 1994-08-23 The Scripps Research Institute GPIbα fragments and recombinant DNA expression vectors
IL88308A0 (en) 1987-11-17 1989-06-30 Scripps Clinic Res Peptides that block the binding of von willebrand factor
US5225538A (en) 1989-02-23 1993-07-06 Genentech, Inc. Lymphocyte homing receptor/immunoglobulin fusion proteins
US5013556A (en) 1989-10-20 1991-05-07 Liposome Technology, Inc. Liposomes with enhanced circulation time
US5462990A (en) * 1990-10-15 1995-10-31 Board Of Regents, The University Of Texas System Multifunctional organic polymers
US6136310A (en) 1991-07-25 2000-10-24 Idec Pharmaceuticals Corporation Recombinant anti-CD4 antibodies for human therapy
US5317097A (en) * 1991-10-07 1994-05-31 The Research Foundation Of State University Of New York Mutations in the gene encoding the α chain on platelet glycoprotein IB
US6277975B1 (en) * 1992-10-23 2001-08-21 Genetics Institute, Inc. Fusions of P-selectin ligand protein and polynucleotides encoding same
US5516964A (en) 1994-01-21 1996-05-14 Sun Company, Inc. (R&M) Hydrocarbon isomerization using solid superacid catalysts comprising platinum metal
JP3735921B2 (ja) * 1996-02-07 2006-01-18 三菱ウェルファーマ株式会社 ＧＰＩｂ・脂質複合体およびその用途
DE69937291T2 (de) * 1998-04-02 2008-07-10 Genentech, Inc., South San Francisco Antikörpervarianten und fragmente davon
ATE417068T1 (de) * 1998-04-23 2008-12-15 Ajinomoto Kk Stoff mit antithrombotischer aktivität und verfahren zur bestimmung von glycokallidin
AR035779A1 (es) * 2001-02-06 2004-07-14 Genetics Inst Llc Polipeptidos de fusion derivados de glicoproteina ib alfa de plaqueta y metodos de uso de los mismos
US6878881B1 (en) * 2004-09-08 2005-04-12 Stephen K. Henry Modular cable protector assembly

Also Published As

Publication number Publication date
US20030232047A1 (en) 2003-12-18
WO2002063003A2 (en) 2002-08-15
US20060093614A1 (en) 2006-05-04
US20090148427A1 (en) 2009-06-11
US6991796B2 (en) 2006-01-31
KR20030074796A (ko) 2003-09-19
PL373052A1 (en) 2005-08-08
AU2006241373A1 (en) 2006-12-14
AU2002240287B2 (en) 2006-08-24
US20030091576A1 (en) 2003-05-15
AU2011200943A1 (en) 2011-03-24
EP1360292A2 (en) 2003-11-12
HUP0303167A2 (hu) 2003-12-29
CN1553955A (zh) 2004-12-08
US20060140935A1 (en) 2006-06-29
CA2437714A1 (en) 2002-08-15
MXPA03007010A (es) 2004-07-08
BR0207039A (pt) 2005-05-03
WO2002063003A3 (en) 2003-05-15
CN100523188C (zh) 2009-08-05
NO20033474L (no) 2003-10-02
NO20033474D0 (no) 2003-08-05
AR035779A1 (es) 2004-07-14
ZA200306229B (en) 2005-05-26
NZ528037A (en) 2006-08-31
US7049128B2 (en) 2006-05-23

Similar Documents

Publication Publication Date Title
HK1095152A1 (en) Platelet glycoprotein ib alpha variant fusion polypeptides and methods of use thereof
HK1072373A1 (en) Virus coat protein/receptor chimeras and methods of use
IL158751A0 (en) Recombinant fusion proteins and the trimers thereof
IL157142A0 (en) Modified antibodies and methods of use
WO2003059257A8 (en) Anti-angiogenic proteins and fragmentsand methods of use thereof
EP1451293A4 (en) NEW SULFURYLASE LUCIFERASE FUSION PROTEINS AND TEMPERATURE STABLE SULFURYLASE
HK1135330A1 (en) Short bioactive peptides and methods for their use
EP1451217A4 (en) NEW PEPTIDES PROVIDING ENVIRONMENTAL RESISTANCE, AND FUSION PROTEINS CONTAINING THOSE PEPTIDES
IL157264A0 (en) Platelet glycoprotein ib alpha fusion polypeptides and methods of use thereof
EP1478748A4 (en) FCE FUSION PROTEINS FOR THE TREATMENT OF ALLERGIES AND ASTHMA
HK1154504A1 (en) Chemokine receptor antagonists and methods of use thereof
AU2002364699A8 (en) Receptors and membrane-associated proteins
IL159872A0 (en) Gmg-2 polypeptides and their use
EP1441030A4 (en) METHOD OF PURIFYING RECOMBINANT FUSED PROTEIN AND PROTEIN PRODUCTION PROCESS USING THE PURIFICATION PROCESS
AU2002251999A1 (en) Methods and compositions for the construction and use of fusion libraries using computational protein design methods
AU8542701A (en) Stress proteins and peptides and methods of use thereof
AU2002363938A8 (en) Methods and use of motoneuronotropic factors
AU2002309970A8 (en) Receptors and membrane-associated proteins
EP1357128A4 (en) PREPARATION AND USE OF A PLASMODIUM FUSION ANTIGEN
EP1423402A4 (en) NOVEL ANALOGUES OF POLYPEPTIDES AND HYBRID PROTEINS AND METHODS OF USE
AU2002322416A1 (en) Gfp fusion proteins and their use
EP1406921A4 (en) HYPOGLYCAEMIC PEPTIDES AND METHOD FOR USE THEREOF
EP1392460A4 (en) AMINOSILANOL HYDROFLUORIDES AND THEIR USE
AU2002245311A8 (en) Human protein kinase n-like polypeptide and uses thereof
GB0108752D0 (en) Peptide epitopes and uses thereof